From PRNewswire and Bio-Medicine.org… link. Results presented at this week’s Digestive Disease Week meeting in Chicago illustrated the effectiveness of BÂRRX Medical, Inc.’s HALO ablation system in the treatment of the pre-cancerous condition known as Barrett’s esophagus. The HALO ablation system uses radiofrequency (RF) energy to remove the epithelium in the esophagus of patients with [...]
Energy-based therapeutics include technologies to effect the destruction or treatment of tissues to remove pathology or otherwise modify tissue (e.g., for creating lesions that block the aberrant signals in arrhythmia). These technologies include radiofrequency, microwave, laser/light, microwave, cryo, hydromechanical, ultrasound and thermal. Some sectors of the energy-based market are growing steadily, others more rapidly. RF [...]
The worldwide high energy therapies market represents a $25 billion opportunity in 2008. The category consists of therapeutic devices and equipment that deliver the controlled application of one or more modalities of energy to tissue. The market will grow at an aggressive rate through 2017 for all modalities, but with some modalities exceeding compound annual [...]
Specific technologies and broad technology platforms have tremendous potential for market growth based on combinations of recent technology advancement, changes in clinical practice, current forces in the market and other criterial. Biotech solutions to traditional medical device technologies. The thrust of medical technology is, and has been for a long time, to make it as effective [...]
The global market for medical devices is currently a $185 billion opportunity and at least 13% of this market involves products that provide the controlled application of energy to tissue. The segment is dominated by high technology products ranging from devices that can heat and cool tissue over a 600° C temperature range of -200° [...]
Medtronic is the predominant player in the energy-based therapies market. With global sales of nearly $4.9 billion attributable to energy-based products, it controls over half of the cardiac rhythm market and almost a quarter of all energy-based product sales. Boston Scientific, also focusing on cardiac arrhythmias, comes next in the revenues table with a $2. [...]
Technologies for ablation and other energy-based treatments in medical/surgical markets are currently dominated by electrosurgical-type therapies, but a growing array of other modalities are creating new applications or penetrating existing ones. These modalities include hydromechanical, microwave, thermal, cryotherapy, ultrasound, radiofrequency (RF), light, radiation (radiosurgery, radiotherapy) and electrical. At right is shown the forecast, by modality [...]
The energy-based medical device industry is led by a diverse group of companies, including small-to-medium pure-play companies specializing in ablation therapies and large multinationals whose interests encompass other classes of medical devices as well as ablation products. Key companies include Medtronic, St. Jude Medical, Varian Medical Systems, Boston Scientific (including Guidant), and Getinge. In terms [...]
From Report #A125, “Ablation Technologies Worldwide, 2008-2017″, published September 2008. See link. Below are selected radiofrequency ablation products, their applications and their status of regulatory approval. [Table=11] For additional information on Report #A125, see link. The report may be purchased online or via Google Checkout, below. USD3,450.00 – Worldwide Ablation Technologies, [...]
Growth in the use of radiofrequency ablation technologies will expand worldwide as it is adopted for use in a wide range of clinical applications spanning cardiology, orthopedics, gynecology, general surgery and others. Below is illustrated the worldwide market growth of RF ablation. Data is drawn from “Worldwide Ablation Technologies 2007-2017, published September 2008, [...]
Contact:
